Gregg C. Fonarow, MD, FACC, FAHA, FHFSA is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA. He serves as Chief of the UCLA Division of Cardiology (Interim), Director of the Ahmanson-UCLA Cardiomyopathy Center, and Co-Director of UCLAs Preventative Cardiology Program. He attained the rank of Professor of Medicine, Geffen School of Medicine at UCLA in 2003. His research interests center on acute and chronic heart failure, preventative cardiology, quality of care, outcomes, and implementing treatment systems to improve clinical outcome. Dr. Fonarow has published over 1500 research studies and clinical trials in heart failure, disease management, preventative cardiology, and outcomes research. Each year 2014 to 2021, Dr. Fonarow has been selected by Clarivate for the list of Highly Cited Researchers, which identifies the worlds most influential contemporary researchers across 21 scientific fields with the greatest number of published articles that received marks for exceptional impact. In 2015, Dr. Fonarow received a Clinical Research Forum Distinguished Clinical Achievement Award. In 2017, Dr. Fonarow received the AHA National Chairmans Award. In 2019, he received the Outstanding Lifetime Achievement Award from the AHA Quality of Care and Outcomes Research Council.